NPA-GP: Glucose Outcomes (2021)
Author and Year:
Weinhold K, Miller C, et al, 2015
PubMed ID:
Article Title:
A randomized controlled trial translating the diabetes prevention program to a university worksite, Ohio, 2012-2014.
Authors:
Weinhold K, Miller C, Marrero D, Nagaraja H, Focht B, Gascon G
Journal:
Preventing Chronic Disease
Year of publication:
2015
Volume:
12
Issue:
Not applicable
Page numbers:
E210
Study Design:
Randomized Controlled Trial
Risk of Bias Assessment Rating:
Some concerns
Inclusion Criteria:
Employee of university; aged 18-65 years old; BMI 25.0-50.0 kg/m2; prediabetes; a score of 5 or more on a 7-item ADA risk assessment questionnaire; fasting finger-stick glucose levels of 100 to 125 mg/dL; if fasting finger-stick glucose level was 95 to 99 or 126 to 140 mg/dL did a finger stick HbA1c and if 5.7% to 6.4% eligible.
Exclusion Criteria:
Completed the Physical Activity Readiness Questionnaire and those who answered positively to 1 or more questions; employees older than 65 years; current diagnosis of type 2 diabetes mellitus; pursuing or recently had weight-loss surgery; taking medication that modifies blood glucose (metformin, corticosteroids); actively participating in a weight-management program; pregnant; breastfeeding; trying to become pregnant; planning to leave employment or move from area within 1 year of study enrollment'.
Research Purpose:
Evaluate the efficacy of a worksite lifestyle intervention among employees with prediabetes; It was hypothesized that the intervention would facilitate greater reductions in the percentage of weight loss than the usual care (control).
Blinding efforts:
Wtatistician (who generated randomization sequence and allocation) was blinded to treatment assignment; neither participants nor lifestyle coaches were blinded to treatment allocation;
Study Location:
major university in the midwestern United States of America
Source(s) of Funding:
Government
Please specify names of funders:
National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health R34DK093907
Trial Name if applicable:
Not applicable